View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AU30 | Publication ID: Spring 2021 |
Title: Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (CMS-4192) | |
Abstract:
This proposed rule would strengthen and improve the Medicare Advantage (MA or Part C) and Medicare Prescription Drug Benefit (Part D) programs, codify existing sub regulatory guidance, and implement any statutory changes (if necessary) for contract year 2023. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
Major: No | Unfunded Mandates: No |
CFR Citation: 42 CFR 422 42 CFR 423 | |
Legal Authority: 42 U.S.C. 1395w |
Legal Deadline:
None |
||||||
Timetable:
|
Regulatory Flexibility Analysis Required: Yes | Government Levels Affected: None |
Small Entities Affected: Businesses, Organizations | Federalism: No |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: Yes | |
Agency Contact: Christian Bauer Director, Division of Part D Policy Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Medicare, MS: C1-26-16, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-6043 Email: christian.bauer@cms.hhs.gov |